Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal ciprofol dose for anesthesia induction in older hypertensive patients
ChiCTR2500106208Phase 2Completed
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Aug 2025
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ciprofol in hypertension (HTN), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoints: Post-induction hypotension (PIH) and Successful induction. Started Aug 2025; status: completed.
02
Drugs
ciprofol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR2500106208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106208.